Coming Soon: 'Wegovy HD'
newser.com • • business
Key Points:
- The higher-dose Wegovy HD helped participants lose about 19% of their body weight (approximately 47 pounds) over nearly 17 months, compared to 16% (39 pounds) with the lower 2.4-milligram dose.
- The FDA recently approved an oral Wegovy pill containing 25 milligrams of semaglutide to ensure absorption via the digestive system.
- Experts believe the higher dose may benefit individuals who do not achieve therapeutic goals with the lower dose or have a suboptimal response to other obesity drugs like Eli Lilly’s Zepbound.
- Side effects such as nausea, vomiting, and constipation occurred in over 70% of participants on the higher dose, with a notable increase in unpleasant skin
